Skip to content

Quality Initiative in Rectal Cancer trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN78363167
Enrollment
672
Registered
2005-08-15
Start date
2002-05-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer Cancer Rectal

Interventions

Surgeons in the 8 hospitals allocated to the experimental arm will be exposed to the QIRC strategy. The strategy includes a workshop, operative demonstrations, use of opinion leaders, audit and feedba
minimum 30 month follow up
study follow up will be completed June 30, 2007).

Sponsors

Juravinski Cancer Centre (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Hospital criteria: An Ontario hospital with a procedure volume of 15 or more major rectal cancer resections per year for fiscal years 1996 to 1998. Patient criteria: 1. Persons of either sex, age groups 18 and above 2. Consecutive patients undergoing major rectal cancer surgery 3. Tumor located within 15 cm of anal verge by rigid sigmoidoscopy, or, at or below the level of the sacral promontory at the time of surgery

Exclusion criteria

Exclusion criteria: Does not comply with the above criteria.

Design outcomes

Primary

MeasureTime frame
1. Rate of permanent colostomy 2. Rate of local recurrence

Secondary

MeasureTime frame
1. Bowel, bladder and sexual function 2. Quality of life

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026